Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equetro in pediatric bipolar I disorder
NCT02623504Phase 4Terminated
- Sponsor
- Validus Pharmaceuticals
- Start
- Oct 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carbamazepine in bipolar I disorder, sponsored by Validus Pharmaceuticals. Started Oct 2016; status: terminated.
02
Drugs
carbamazepine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT02623504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02623504.